NSD2 and cancer: Nuclear receptor-binding SET domain-containing 2 (NSD2),a methyltransferasethat primarily installs the dimethyl mark on lysine 36 of histone3 (H3K36me2), has been recognized as a promising therapeutic targetagainst cancer.